Skip to main content
logo
Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.84
+0.19 (1.30%)
Sep 30, 2026, 4:08 PM HKT

HKG:1681 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,1751,078910.46784.53682.91590.17
Depreciation & Amortization
68.0466.5963.9978.0976.3672.99
Loss (Gain) From Sale of Assets
1.931.930.350.854.121.99
Loss (Gain) From Sale of Investments
-3.47-3.470.09-0.23--
Loss (Gain) on Equity Investments
1.61.60.07---
Stock-Based Compensation
-----1.7823.41
Provision & Write-off of Bad Debts
-1.02-1.02-8.78-12.6-32.49-18.04
Other Operating Activities
166.43-23.85-33.07-14.3339.93-90.34
Change in Accounts Receivable
-21.51-21.51-27.9-1.71113.87114.21
Change in Inventory
18.2718.2777.41-89.69-54.9-39.56
Change in Accounts Payable
138.57138.57116.9280.76114.4150.99
Change in Unearned Revenue
-1.94-1.94-4.55-0.462.261.67
Change in Other Net Operating Assets
-41.44-41.44-8.01-6.24318.04
Operating Cash Flow
1,5011,2121,087818.97947.68725.54
Operating Cash Flow Growth
22.06%11.48%32.73%-13.58%30.62%-16.32%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-72.48-68.48-109-52.56-51.59-98.25
Sale of Property, Plant & Equipment
-0.03-0.330.151.20.32
Cash Acquisitions
-26.4-----
Sale (Purchase) of Intangibles
-1,018-1,018----
Investment in Securities
-652.94-1,121-143.06-248.27-365.67-230
Other Investing Activities
77.9954.0564.8268.9247.2629.62
Investing Cash Flow
-1,691-2,153-186.91-231.77-368.8-298.31

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-223.07497.55442.39259.32295.72
Long-Term Debt Repaid
--276.38-758.2-382.93-436.67-235.81
Lease Payments
1.23-0.91-4.86-3.51-2.86-2.93
Net Debt Issued (Repaid)
-21.36-53.32-260.6559.46-177.3559.91
Issuance of Common Stock
10.3816.03142.9914.22.6414.57
Repurchase of Common Stock
-177.99-168.02---29.07-30.15
Common Dividends Paid
-557.58-498.39-680.54-326.25-127.49-198.08
Other Financing Activities
-9.48-8.0468.94-27.51-10.93-12.91
Financing Cash Flow
-756.04-711.74-729.26-280.1-342.21-166.66

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-27.4-20.24-11.4-9.0117.18-4.52
Net Cash Flow
-974.39-1,673159.42298.09253.85256.05

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,4281,143977.99766.41896.09627.29
Free Cash Flow Growth
24.93%16.91%27.61%-14.47%42.85%-23.35%
Free Cash Flow Margin
39.30%33.46%32.96%29.59%38.30%30.68%
Free Cash Flow Per Share
1.681.341.180.961.130.78
Levered Free Cash Flow
149.99-208.28681.72507.99650.74464.15
Unlevered Free Cash Flow
152.85-205.55697.28521.28657.57472.21
Free Cash Flow After Leases
1,4291,142973.13762.9893.23624.36

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4.584.3624.891.090.5612.91
Cash Income Tax Paid
63.1634.337.1820.0313.21134.68
Change in Working Capital
91.9491.94153.88-17.34178.64145.35